In Germany, the research & development by business enterprise, pharmaceutical industry in constant ppp $ stands at 6,316.45 million, reflecting an increase of 137.82 million (2.2%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Germany
No matching regions
Similar regions to Germany
Business R&D pharmaceutical in constant PPP $
More indicators for Germany
Government R&D in security as % of government support
4.2%
+0%
(2021)
Higher-education-finacing R&D financed by general university in local currency
53,957.00M
-1,258.00M
(2005)
R&D financed by rest of the world in local currency
78,509.07M
+600.72M
(2021)
Government R&D financed by rest of the world in local currency
10,120.47M
+1,554.23M
(2021)
Business R&D financed by rest of the world in local currency
59,822.55M
-513.58M
(2021)
Non-profit R&D growth rate
7.81%
+9.62%
(2022)
Germany Business R&D pharmaceutical in constant PPP $ between 1991 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 6,316.45M | +137.82M |
| 2020 | 6,178.62M | -338.66M |
| 2019 | 6,517.29M | +115.33M |
| 2018 | 6,401.95M | +615.57M |
| 2017 | 5,786.38M | +56.31M |
| 2016 | 5,730.08M | +646.04M |
| 2015 | 5,084.04M | -197.13M |
| 2014 | 5,281.16M | -152.92M |
| 2013 | 5,434.08M | -129.73M |
| 2012 | 5,563.81M | -52.49M |
| 2011 | 5,616.29M | +404.26M |
| 2010 | 5,212.04M | -257.11M |
| 2009 | 5,469.15M | +587.92M |
| 2008 | 4,881.23M | +103.63M |
| 2007 | 4,777.60M | -589.81M |
| 2006 | 5,367.41M | +361.48M |
| 2005 | 5,005.93M | +333.06M |
| 2004 | 4,672.88M | +76.47M |
| 2003 | 4,596.40M | +808.60M |
| 2002 | 3,787.80M | +281.30M |
| 2001 | 3,506.50M | +16.08M |
| 2000 | 3,490.42M | +251.31M |
| 1999 | 3,239.11M | +222.54M |
| 1998 | 3,016.57M | +44.33M |
| 1997 | 2,972.24M | +579.75M |
| 1996 | 2,392.49M | +416.95M |
| 1995 | 1,975.54M | -159.85M |
| 1994 | 2,135.39M | -247.92M |
| 1993 | 2,383.30M | -182.79M |
| 1992 | 2,566.09M | -131.52M |
| 1991 | 2,697.61M |